VALEANT PHARMACEUTICALS INTL's ticker is VRX and the CUSIP is 91911K102. A total of 330 filers reported holding VALEANT PHARMACEUTICALS INTL in Q2 2017. The put-call ratio across all filers is 1.24 and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2018 | $27,673,000 | +122.2% | 1,190,261 | +52.2% | 0.00% | +200.0% |
| Q1 2018 | $12,453,000 | -66.8% | 782,232 | -56.7% | 0.00% | -75.0% |
| Q4 2017 | $37,513,000 | +960.9% | 1,805,270 | +631.6% | 0.00% | – |
| Q3 2017 | $3,536,000 | +19.7% | 246,770 | +44.6% | 0.00% | – |
| Q2 2017 | $2,953,000 | +376.3% | 170,670 | +203.8% | 0.00% | – |
| Q1 2017 | $620,000 | -98.0% | 56,170 | -97.4% | 0.00% | -100.0% |
| Q4 2016 | $31,223,000 | -82.9% | 2,150,369 | -71.1% | 0.00% | -83.3% |
| Q3 2016 | $182,549,000 | -41.7% | 7,435,829 | -52.2% | 0.02% | -44.2% |
| Q2 2016 | $313,087,000 | +118.6% | 15,545,539 | +185.4% | 0.04% | +115.0% |
| Q1 2016 | $143,231,000 | -84.7% | 5,446,046 | -40.8% | 0.02% | -84.1% |
| Q4 2015 | $934,652,000 | -59.3% | 9,200,743 | -28.5% | 0.13% | -61.5% |
| Q3 2015 | $2,295,704,000 | -15.2% | 12,861,850 | +5.3% | 0.33% | -5.8% |
| Q2 2015 | $2,708,592,000 | +16.8% | 12,209,441 | +4.1% | 0.35% | +17.6% |
| Q1 2015 | $2,318,359,000 | +35.0% | 11,732,842 | -2.2% | 0.30% | +32.3% |
| Q4 2014 | $1,717,498,000 | +21.2% | 11,996,844 | +10.9% | 0.22% | +16.1% |
| Q3 2014 | $1,417,546,000 | -21.0% | 10,817,449 | -23.8% | 0.19% | -20.3% |
| Q2 2014 | $1,794,555,000 | -40.4% | 14,191,933 | -38.0% | 0.24% | -42.3% |
| Q1 2014 | $3,011,350,000 | -1.8% | 22,888,433 | -12.4% | 0.42% | -3.5% |
| Q4 2013 | $3,065,102,000 | -3.0% | 26,126,197 | -13.8% | 0.43% | -10.5% |
| Q3 2013 | $3,160,499,000 | +17.1% | 30,310,968 | -3.2% | 0.48% | +9.5% |
| Q2 2013 | $2,698,878,000 | – | 31,303,568 | – | 0.44% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Brave Warrior Advisors | 6,050,442 | $763,082,000 | 30.78% |
| LeVasseur Capital Partners LLC | 190,404 | $24,014,000 | 29.50% |
| FARLEY CAPITAL L.P. | 333,081 | $42,008,000 | 27.09% |
| Ruane, Cunniff & Goldfarb | 34,298,384 | $4,325,712,000 | 23.07% |
| ValueAct Holdings | 18,923,877 | $2,386,679,000 | 17.64% |
| Tesuji Partners | 1,368,040 | $172,537,000 | 17.22% |
| Brahman Capital Corp. | 3,902,877 | $492,231,000 | 13.63% |
| Arrow Capital Management, LLC | 197,500 | $24,909,000 | 13.60% |
| Hound Partners | 2,851,175 | $359,590,000 | 13.45% |
| Ratan Capital Management LP | 731,960 | $92,315,000 | 13.09% |